Latest Breaking News On - Eli lilly co - Page 1 : comparemela.com

Bonds Rise on Treasury Sale; Asian Stocks to Fall: Markets Wrap

Alzheimer's drug that slows disease gets backing from FDA advisers

The FDA will make the final decision on approval later this year

FDA advisory committee backs donanemab for early-stage Alzheimer's

An FDA advisory panel on Monday voted in favor of donanemab as a treatment for early symptomatic Alzheimer’s disease.In a press conference on June 10, the Peripheral and Central Nervous System Drugs Advisory Committee ruled 11-0 that donanemab (Eli Lilly & Co.), a once-per-month, 30-minute infusion treatment, was effective in treating individuals with mild cognitive impairment and mild

Alzheimer's drug that can slow disease gets backing from FDA advisers | News, Sports, Jobs

Alzheimer's could be a 'very big category' for Eli Lilly: Dr Gottlieb

Eli Lilly received backing for its Alzheimer's drug from FDA advisors today. Dr Scott Gottlieb discussed the development on CNBC.